Harbor Capital Advisors Inc. Reduces Position in Option Care Health, Inc. (NASDAQ:OPCH)

Harbor Capital Advisors Inc. trimmed its holdings in shares of Option Care Health, Inc. (NASDAQ:OPCH) by 33.4% in the 1st quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 142,056 shares of the company’s stock after selling 71,099 shares during the period. Harbor Capital Advisors Inc. owned approximately 0.09% of Option Care Health worth $4,965,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds have also bought and sold shares of OPCH. Murphy & Mullick Capital Management Corp acquired a new stake in Option Care Health during the 4th quarter valued at approximately $26,000. Signaturefd LLC lifted its stake in Option Care Health by 487.9% during the 4th quarter. Signaturefd LLC now owns 1,211 shares of the company’s stock valued at $28,000 after acquiring an additional 1,005 shares during the period. Quadrant Capital Group LLC lifted its stake in Option Care Health by 172.8% during the 4th quarter. Quadrant Capital Group LLC now owns 1,735 shares of the company’s stock valued at $40,000 after acquiring an additional 1,099 shares during the period. Public Employees Retirement System of Ohio lifted its stake in Option Care Health by 21.6% during the 4th quarter. Public Employees Retirement System of Ohio now owns 1,870 shares of the company’s stock valued at $43,000 after acquiring an additional 332 shares during the period. Finally, Johnson Financial Group Inc. acquired a new stake in Option Care Health during the 4th quarter valued at approximately $47,000. 98.05% of the stock is currently owned by institutional investors and hedge funds.

Analysts Set New Price Targets

Several equities analysts recently issued reports on OPCH shares. JPMorgan Chase & Co. boosted their target price on shares of Option Care Health from $40.00 to $41.00 and gave the company an “overweight” rating in a research note on Thursday, March 6th. Barrington Research reiterated an “outperform” rating and issued a $38.00 target price on shares of Option Care Health in a research note on Wednesday, April 30th. JMP Securities reiterated a “market outperform” rating and issued a $36.00 target price on shares of Option Care Health in a research note on Tuesday, April 22nd. Finally, UBS Group upgraded shares of Option Care Health from a “neutral” rating to a “buy” rating and boosted their target price for the company from $38.00 to $40.00 in a research note on Wednesday, April 30th. One analyst has rated the stock with a hold rating and seven have issued a buy rating to the company. According to MarketBeat.com, Option Care Health currently has an average rating of “Moderate Buy” and a consensus target price of $35.50.

Option Care Health Price Performance

Shares of NASDAQ OPCH opened at $32.15 on Wednesday. The firm has a market cap of $5.26 billion, a PE ratio of 27.02, a PEG ratio of 2.30 and a beta of 0.74. The firm has a fifty day moving average of $32.30 and a 200 day moving average of $30.14. The company has a debt-to-equity ratio of 0.77, a quick ratio of 1.32 and a current ratio of 1.73. Option Care Health, Inc. has a one year low of $21.39 and a one year high of $35.53.

Option Care Health (NASDAQ:OPCH) last issued its quarterly earnings results on Tuesday, April 29th. The company reported $0.40 EPS for the quarter, topping the consensus estimate of $0.36 by $0.04. The company had revenue of $1.33 billion during the quarter, compared to analyst estimates of $1.26 billion. Option Care Health had a net margin of 4.37% and a return on equity of 15.30%. The firm’s revenue was up 16.3% compared to the same quarter last year. During the same quarter in the previous year, the firm earned $0.26 EPS. As a group, research analysts predict that Option Care Health, Inc. will post 1.22 EPS for the current fiscal year.

Option Care Health Profile

Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn’s disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.